Specify a stock or a cryptocurrency in the search bar to get a summary
Stratec SE
SBSStratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Address: Gewerbestrasse 37, Birkenfeld, Germany, 75217
Analytics
WallStreet Target Price
96.04 EURP/E ratio
41.5244Dividend Yield
1.61 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SBS
Dividend Analytics SBS
Dividend growth over 5 years
21 %Continuous growth
18 yearsPayout Ratio 5 years average
55 %Dividend History SBS
Stock Valuation SBS
Financials SBS
Results | 2019 | Dynamics |